| Schedule of computation of basic and diluted net loss per common share |
| Schedule of computation of basic and diluted net loss per
common share | |
| | | |
| | | |
| | | |
| | |
| | |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Numerator: | |
| | | |
| | | |
| | | |
| | |
| Net income (loss) attributable to common stockholders, basic | |
$ | (1,835 | ) | |
$ | 2,700 | | |
$ | (3,145 | ) | |
$ | 1,930 | |
| Series D preferred stock dividend | |
| (227 | ) | |
| – | | |
| (227 | ) | |
| – | |
| Effect of potentially dilutive securities: | |
| | | |
| | | |
| | | |
| | |
| After-tax interest expense on convertible notes | |
| – | | |
| 14 | | |
| – | | |
| 14 | |
| Net income (loss) attributable to common stockholders | |
$ | (2,062 | ) | |
$ | 2,714 | | |
$ | (3,372 | ) | |
$ | 1,944 | |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted-average common shares outstanding, basic | |
| 186,174,045 | | |
| 51,776,206 | | |
| 179,284,550 | | |
| 47,154,964 | |
| Effect of potentially dilutive securities: | |
| | | |
| | | |
| | | |
| | |
| Convertible notes | |
| – | | |
| 14,500,000 | | |
| – | | |
| 7,250,000 | |
| Restricted stock | |
| – | | |
| – | | |
| – | | |
| 3,513,362 | |
| Weighted-average common shares outstanding, diluted | |
| 186,174,045 | | |
| 66,276,206 | | |
| 179,284,550 | | |
| 57,918,326 | |
| | |
| | | |
| | | |
| | | |
| | |
| Net income (loss) per share attributable to common stockholders, | |
| | | |
| | | |
| | | |
| | |
| Basic | |
$ | (0.01 | ) | |
$ | 0.05 | | |
$ | (0.02 | ) | |
$ | 0.04 | |
| Diluted | |
$ | (0.01 | ) | |
$ | 0.04 | | |
$ | (0.02 | ) | |
$ | 0.03 | |
|
| Schedule of anti-dilutive shares |
| Schedule of anti-dilutive shares | |
| | | |
| | | |
| | | |
| | |
| | |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Series C Preferred Shares | |
| 11,983,000 | | |
| – | | |
| 11,983,000 | | |
| – | |
| Series D Preferred Shares | |
| 34,677,751 | | |
| – | | |
| 34,677,751 | | |
| – | |
| Senior Secured Notes, including accrued interest | |
| 168,184 | | |
| 140,612 | | |
| 168,184 | | |
| 140,612 | |
| Convertible Notes, excluding accrued interest | |
| 75,000,000 | | |
| – | | |
| 75,000,000 | | |
| – | |
| Warrants to purchase common stock | |
| 85,063,587 | | |
| 62,549,982 | | |
| 85,063,587 | | |
| 62,549,982 | |
| Stock options to purchase common stock | |
| 50,843,036 | | |
| 1,103,451 | | |
| 50,843,036 | | |
| 1,103,451 | |
| Unvested Shares | |
| 1,129,630 | | |
| 1,129,630 | | |
| 1,129,630 | | |
| 1,129,630 | |
| Restricted stock | |
| – | | |
| 65,000,000 | | |
| – | | |
| – | |
| Restricted stock units | |
| 25,000 | | |
| 25,000 | | |
| 25,000 | | |
| 25,000 | |
| Anti-dilutive shares | |
| 258,890,188 | | |
| 129,948,675 | | |
| 258,890,188 | | |
| 64,948,675 | |
|